Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FN4AQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,293
Award facts
- Contract value 100% obligated
- $13,293.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors with a ceiling value of $13,293.08. This firm fixed-price delivery order, which is effective through August 27, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic conditions, and asthma, making this a specialized pharmaceutical supply supporting military and Department of Defense healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen maintains a comprehensive portfolio of pharmaceutical and medical supply distribution capabilities serving Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The company's established track record of competitively awarded contracts across multiple therapeutic domains positions it as a critical vendor supporting military medical readiness and personnel healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FN4AQ?
SPE2DB25FN4AQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FN4AQ worth?
The government has obligated $13,293 on SPE2DB25FN4AQ.
Is contract SPE2DB25FN4AQ an order under another contract?
Yes. SPE2DB25FN4AQ is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4AQ competed?
The extent of competition for SPE2DB25FN4AQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award